Daily FNArena News - Australia

Weekly Update on ASX-listed companies buying in their own stock.

Uncertainty from several quarters is clouding the outlook for Primary Health Care as the company guides to a softer FY16. Broker reactions vary.

Myer enjoyed reasonable sales growth in the first quarter, its strongest in five years. While encouraged, several brokers remain unconvinced.

Weekly update on recommendation, target price, and earnings forecast changes.

Programmed Maintenance is suffering from exposure to the resource sectors, but other sectors are preforming strongly and the Skilled Group merger offers significant synergies.

James Hardie missed its targets again in the first half, with growth in US market share stalling amid soft volumes. Most brokers are still willing to give the company the benefit of the doubt.

Orica is a little more confident in its FY16 outlook after a very difficult FY15 but brokers remain cautious, most not yet ready to call an end to weakness.

FNArena’s weekly update on short positions in the Australian share market.

FNArena provides a weekly update of Australian listed corporate bond issues, current pricing and yield data.

Weekly Update on ASX-listed companies buying in their own stock.